These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 31978347)

  • 1. Quantitative Proteomics of the Cancer Cell Line Encyclopedia.
    Nusinow DP; Szpyt J; Ghandi M; Rose CM; McDonald ER; Kalocsay M; Jané-Valbuena J; Gelfand E; Schweppe DK; Jedrychowski M; Golji J; Porter DA; Rejtar T; Wang YK; Kryukov GV; Stegmeier F; Erickson BK; Garraway LA; Sellers WR; Gygi SP
    Cell; 2020 Jan; 180(2):387-402.e16. PubMed ID: 31978347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiling of more than 3500 proteins of MSS-type colorectal cancer by stable isotope labeling and mass spectrometry.
    Kang UB; Yeom J; Kim HJ; Kim H; Lee C
    J Proteomics; 2012 Jun; 75(10):3050-62. PubMed ID: 22154799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.
    Manes NP; Nita-Lazar A
    J Proteomics; 2018 Oct; 189():75-90. PubMed ID: 29452276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome analysis in the study of lymphoma cells.
    Joubert-Caron R; Caron M
    Mass Spectrom Rev; 2005; 24(4):455-68. PubMed ID: 15389845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep proteome and transcriptome mapping of a human cancer cell line.
    Nagaraj N; Wisniewski JR; Geiger T; Cox J; Kircher M; Kelso J; Pääbo S; Mann M
    Mol Syst Biol; 2011 Nov; 7():548. PubMed ID: 22068331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics-based identification of biomarkers for predicting sensitivity to a PI3-kinase inhibitor in cancer.
    Akashi T; Nishimura Y; Wakatabe R; Shiwa M; Yamori T
    Biochem Biophys Res Commun; 2007 Jan; 352(2):514-21. PubMed ID: 17137555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells.
    Fricke F; Lee J; Michalak M; Warnken U; Hausser I; Suarez-Carmona M; Halama N; Schnölzer M; Kopitz J; Gebert J
    Cell Commun Signal; 2017 Apr; 15(1):14. PubMed ID: 28376875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping Cellular Microenvironments: Proximity Labeling and Complexome Profiling (Seventh Symposium of the Göttingen Proteomics Forum).
    Valerius O; Asif AR; Beißbarth T; Bohrer R; Dihazi H; Feussner K; Jahn O; Majcherczyk A; Schmidt B; Schmitt K; Urlaub H; Lenz C
    Cells; 2019 Oct; 8(10):. PubMed ID: 31581721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer proteomics by quantitative shotgun proteomics.
    Chen EI; Yates JR
    Mol Oncol; 2007 Sep; 1(2):144-59. PubMed ID: 18443658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome profiling of breast cancer biopsies reveals a wound healing signature of cancer-associated fibroblasts.
    Groessl M; Slany A; Bileck A; Gloessmann K; Kreutz D; Jaeger W; Pfeiler G; Gerner C
    J Proteome Res; 2014 Nov; 13(11):4773-82. PubMed ID: 25238572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches for systematic proteome exploration.
    Falk R; Ramström M; Ståhl S; Hober S
    Biomol Eng; 2007 Jun; 24(2):155-68. PubMed ID: 17376740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perseus: A Bioinformatics Platform for Integrative Analysis of Proteomics Data in Cancer Research.
    Tyanova S; Cox J
    Methods Mol Biol; 2018; 1711():133-148. PubMed ID: 29344888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning multi-omics analysis reveals cancer driver dysregulation in pan-cancer cell lines compared to primary tumors.
    Sanders LM; Chandra R; Zebarjadi N; Beale HC; Lyle AG; Rodriguez A; Kephart ET; Pfeil J; Cheney A; Learned K; Currie R; Gitlin L; Vengerov D; Haussler D; Salama SR; Vaske OM
    Commun Biol; 2022 Dec; 5(1):1367. PubMed ID: 36513728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies.
    Berg KCG; Eide PW; Eilertsen IA; Johannessen B; Bruun J; Danielsen SA; Bjørnslett M; Meza-Zepeda LA; Eknæs M; Lind GE; Myklebost O; Skotheim RI; Sveen A; Lothe RA
    Mol Cancer; 2017 Jul; 16(1):116. PubMed ID: 28683746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-model statistical approach for proteomic spectral count quantitation.
    Branson OE; Freitas MA
    J Proteomics; 2016 Jul; 144():23-32. PubMed ID: 27260494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
    Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
    World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing cellular complexity with proteomics.
    Blackstock W; Rowley A
    Curr Opin Mol Ther; 1999 Dec; 1(6):702-11. PubMed ID: 19629867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum proteomics profiling--a young technology begins to mature.
    Coombes KR; Morris JS; Hu J; Edmonson SR; Baggerly KA
    Nat Biotechnol; 2005 Mar; 23(3):291-2. PubMed ID: 15765078
    [No Abstract]   [Full Text] [Related]  

  • 19. Optomechanical devices for deep plasma cancer proteomics.
    Kosaka PM; Calleja M; Tamayo J
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quantitative proteome of a human cell line.
    Beck M; Schmidt A; Malmstroem J; Claassen M; Ori A; Szymborska A; Herzog F; Rinner O; Ellenberg J; Aebersold R
    Mol Syst Biol; 2011 Nov; 7():549. PubMed ID: 22068332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.